Clinical trial

A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

NCT01942161

Study summary

ClinicalTrials.gov

A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Aripiprazole Low (2 mg/day) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Aripiprazole Mid (6 - 12 mg/day) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Aripiprazole High (24 - 30 mg/day) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-01

PhasePHASE2 / PHASE3

Conditions

Schizophreniaverified · MONDO: schizophrenia

Interventions

Aripiprazole Low (2 mg/day)DRUG

Aripiprazole Mid (6 - 12 mg/day)DRUG

Aripiprazole High (24 - 30 mg/day)DRUG

Sponsors & collaborators

Otsuka Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01942161 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.